2002 Clinical Trials Edibles 
The Cannigma
MAY 17, 2022
A 2002 study found that smoking cannabis increased blood flow in the frontal lobe, an area that’s thought to play an important role in abstract thought, creative thinking and sensory processing. 15 Multiple clinical trials have shown that linalool in ylang ylang oil and lavender oil “significantly increased calmness.”
The Cannigma
AUGUST 14, 2022
A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. Oral delivery methods like tinctures and edibles have a longer effect time, while inhaled cannabis (like smoking or vaping) delivers results quickly, but also fades quickly. How you consume matters too.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. A typical dose is 150-500 mcg.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2002 Jun;42(8):993-1007.
Expert insights. Personalized for you.
127 
Let's personalize your content